JP5299695B2 - Chemical volatilizer - Google Patents

Description

  The present invention relates to a chemical volatilizer that volatilizes a prescription solution contained in a container. In the present specification, the “prescription liquid” means a liquid in which a medicine according to a function (aroma effect / deodorizing effect / deodorizing effect / insect repellent effect, etc.) to be given to the medicine volatilizer is prescribed. To do.

  For example, small chemical volatilizers (fragrances) that volatilize fragrances and the like naturally are widely used in order to eliminate the discomfort caused by odors in indoor spaces such as homes and private cars, and to create comfortable spaces.

  In this chemical volatilizer, chemicals such as gel, solid and liquid are used. A chemical volatilizer using a liquid chemical (chemical solution) generally includes a container having an opening at the top and containing a chemical solution and a suction volatilization member, and one end of the suction volatilization member is immersed in the chemical solution. The end is configured to be exposed from the opening of the container to the indoor space.

  Capillary phenomenon is usually used for wicking volatilization by the wicking member, and the prescription solution is sucked up at the wicking portion, and the chemical solution is volatilized in the air at the volatile portion. For this reason, as the wicking member, for example, a non-woven fabric such as felt, or a water-absorbing member in which a fibrous material such as pulp or synthetic fiber is lightly consolidated is used.

  Patent Documents 1 and 2 have a configuration in which the aromatic liquid in the container is volatilized from the wicking volatilization member by pulling up the wicking volatilization member housed in the container so as to be exposed to the outside air from the opening at the top of the container. A fragrance is disclosed.

  Patent Document 3 discloses an aroma deodorizer configured such that the aromatic liquid in the container is sucked up by the suction core material, and the aromatic liquid in the container is volatilized from the volatilization member provided on the upper part of the suction core material. ing.

  Patent Document 4 discloses a decorative body having a configuration in which crystals colored in a plurality of colors are deposited on the tip of a decorative water-absorbing substrate.

  Patent Document 5 has a volatilizer having a suction volatilization member that is exposed to the outside of a container, and volatilizes a solvent supplied to the suction volatilization member, so that a pattern appears on the suction volatilization member. It is disclosed.

  Patent Document 6 discloses a functional material configured to apply a wax agent in which a volatile drug and a pigment are mixed to a sheet on which a pattern is printed, and the sheet pattern appears when the drug volatilizes about 80%. Yes.

  Patent Document 7 discloses a chemical solution volatilization device comprising a gas-impermeable layer, a base whose refractive index changes due to drug permeation, and a drug-permeable base, wherein the pattern changes in three steps with weight reduction. ing.

  The drug volatilizer described above is often installed in a place where it can be seen by a person such as a home (living room, entrance, toilet, etc.) or a car. For this reason, the chemical volatilizer is also required to have interior characteristics. As a result, the interior characteristics of the appearance are regarded as important, and the design characteristics of the containers are emphasized. On the other hand, with respect to the wicking volatilization member having a portion exposed from the container, the functional aspect of ensuring a large exposed area (volatilization area) is emphasized, but the design of the wicking volatilization member is not sufficiently considered.

  In the said patent document 5, although the structure by which a pattern appears on a wicking volatilization member is volatilized by volatilizing the solvent supplied to the wicking volatilization member, the front-end | tip part of a wicking volatilization member is colored with a pigment | dye. Although it is possible to visually recognize the effect of fragrance, it has not been considered to improve the design by locally applying an arbitrarily shaped pattern.

JP 2005-000329 A JP 2007-105447 A JP 2008-086528 A JP 07-329498 A JP 2004-329794 A JP 2003-033428 A JP 09-117243 A

  This invention was made in order to solve the above-mentioned problem, and in a chemical volatilizer that volatilizes a prescription solution contained in a container, a volatilization unit capable of locally expressing a picture or character of any shape It aims at providing the chemical volatilizer which has this.

  In the drug volatilizer based on the present invention, a container having an opening, a prescription liquid containing a non-volatile substance in a volatile liquid contained in the container, and disposed in the opening, sucking up the prescription liquid A suction volatilization member that volatilizes the volatile liquid in the formulation liquid.

  A pattern display area is provided on the surface of the wicking volatilization member, and the pattern display area has a surface roughness of the pattern display area so that the prescription liquid is sucked more toward the tip by capillary action. However, it is provided larger than the surface roughness of the suction volatilization member in which the picture display area is not provided.

  According to the chemical volatilizer based on this invention, it becomes possible to provide the chemical volatilizer which has a volatilization part which can make a pattern and a character of arbitrary shapes express locally.

It is a figure which shows the whole structure of the chemical volatilization device in Embodiment 1. FIG. It is sectional drawing which shows the whole structure except the volatilization part of the chemical volatilization device in Embodiment 1. FIG. It is sectional drawing which shows the structure of the holding | maintenance frame and volatilization part of a chemical volatilizer in Embodiment 1. FIG. It is a figure which shows the whole structure in the state which pulled up the volatilization part of the chemical volatilization device in Embodiment 1. FIG. It is a figure which shows the state which expand | deployed the volatilization part in Embodiment 1. FIG. It is a figure which shows the pattern area | region provided in the volatilization part in Embodiment 1, (A) is a figure which shows the state before a change, (B) is a figure which shows the state after a change. It is a VII-VII line arrow directional cross-sectional view in FIG. It is sectional drawing which shows the other form of the volatilization part in Embodiment 1. FIG. It is sectional drawing which shows the further another form of the volatilization part in Embodiment 1. FIG. It is sectional drawing which shows the whole structure before use of the chemical volatilization device in Embodiment 2. FIG. It is sectional drawing which shows the whole structure at the time of use of the chemical volatilization device in Embodiment 2. It is a figure which shows the pattern area | region provided in the volatilization part in Embodiment 2, (A) is a figure which shows the state before a change, (B) is a figure which shows the state after a change.

  Hereinafter, the chemical volatilizer in each embodiment of the present invention will be described with reference to the drawings. In each embodiment described below, when referring to the number, amount, and the like, the scope of the present invention is not necessarily limited to the number, amount, and the like unless otherwise specified. The same parts and corresponding parts are denoted by the same reference numerals, and redundant description may not be repeated. In addition, when there are a plurality of embodiments below, it is planned from the beginning to appropriately combine the configurations of the embodiments unless otherwise specified.

(Embodiment 1)
(Overall configuration of drug volatilizer 1A)
With reference to FIGS. 1-3, the whole structure of 1 A of chemical | medical agent volatilizers in this Embodiment is demonstrated. In the drug volatilizer 1 </ b> A, a cap 7 is screwed into the opening 2 at the upper end of the container 3. A holding frame 8 that is rotatably connected to the cap 7 at its upper end is attached to the cap 7.

  A prescription liquid 4 is accommodated inside the container 3. The prescription liquid 4 gradually decreases with the use of the chemical volatilizer 1 </ b> A, but occupies about 80% of the container 3 when the use is disclosed. The details of the prescription liquid 4 will be described later.

  A connecting portion 9 provided with a fitting hole 9 a is provided at the upper end portion of the holding frame 8. The holding frame 8 is rotatably connected to the cap 7 by fitting the fitting hole 9a of the connecting portion 9 into the boss 7a provided protruding from the top inner surface of the cap 7.

  The boss 7a has a tip crest 7b formed into a claw shape in a tri-section state, and a detent step 7c is provided on the outer surface of each claw. By press-fitting the distal end head portion 7 b into the fitting hole 9 a, the stepped portion 7 c is engaged with the outer peripheral edge of the lower surface of the connecting portion 9, and the boss 7 a does not come out of the connecting portion 9, so Can be rotated.

  On both sides of the lower surface of the connecting portion 9, reinforcing plates 9b are provided. The reinforcing plate 9 b is provided with an outer frame 8 a that extends to the lower inside of the container 3. A locking portion 8b that protrudes outward from the outer frame 8a is provided at the lower end of the outer frame 8a. When the holding frame 8 is pulled up, the holding frame 8 is locked to the neck 14 of the container 3 to prevent the holding frame 8 from coming out.

  FIG. 3 shows an example of how the suction volatilization member 6 is attached to the holding frame 8. The details of the suction volatilization member 6 will be described later. The suction volatilization member 6 having a strip shape has a configuration in which the suction part 6a and the volatilization part 6b are continuously integrated. The volatilization part 6 b is attached to the holding frame 8 so as to be wound around the holding frame 8. The suction part 6 a is attached so as to be suspended from the lower end part of the holding frame 8.

  In addition, regarding the wicking volatilization member 6, although the whole shape is a strip | belt shape and the width of the volatilization part 6b is larger than the width | variety of the wicking part 6a, it has illustrated, the width | variety of the wicking part 6a and a volatilization part The width of 6b may be the same. Moreover, the shape of the wicking volatilization member 6 is not limited to a strip shape. Any shape that has the effect of sucking the prescription liquid and volatilizing, such as a cylindrical shape or a string shape, can be used.

  In the chemical volatilizer 1 </ b> A having the above-described configuration, in the state where the cap 7 is screwed into the opening 2 of the container 3, the suction part 6 a is immersed in the prescription liquid 4, and almost the entire volatilization part 6 b is prescription liquid 4. Soaked in

  FIG. 4 shows a state in which the holding frame 8 is pulled up using the cap 7. The volatilization part 6b is exposed to the outside air above the opening 2, and the volatile components of the prescription liquid 4 are volatilized in the air. By adjusting the lifting amount of the holding frame 8, the volatilization amount of the prescription liquid 4 can be adjusted. Moreover, an odor component can also be absorbed in the volatilization part 6b.

  As shown in the development view of the wicking volatilization member 6 in FIG. 5, a pattern display region 100 is provided in a predetermined region on the surface side of the volatilization portion 6 b in the present embodiment. In addition, the surface side of the volatilization part 6b shall mean the side located in the outer side in the attachment state to the holding frame 8 of the volatilization part 6b shown in FIG. In addition, the pattern display area 100 is provided at a position where the volatilization part 6 b is wound around the holding frame 8 and fixed and then touched by human eyes. Note that the pattern display area 100 is an area in which a picture, a pattern, a pattern, a character, or an area formed by a combination thereof is displayed so as to emerge due to a color difference from another area.

  In the pattern display area 100, a flocked area is provided. Thereby, the prescription liquid 4 is sucked up toward the tip portion by capillary action at the flocked portion of the pattern display region 100 from the time of use disclosure in which the holding frame 8 is pulled up and the volatilization portion 6b is exposed to the outside air. Volatilizes. As a result, as shown in FIG. 6A, the color tone is the same as a whole at the start of use, but with the passage of time, the non-volatile content in the prescription liquid 4 is present at the tip of the flocked area of the pattern display area 100. The component dye is accumulated. As a result, the color of the pigment at the tip of the flocked area of the pattern display area 100 gradually increases. Thereby, as shown to FIG. 6 (B), a floral pattern can be clearly surfaced in the volatilization part 6b.

  In this way, on the surface side of the volatilization part 6b, when comparing the color change of the area where the pattern display area 100 is not provided with the color change of the area where the pattern display area 100 is provided, Since the pattern display area 100 has better volatility, a non-volatile component, which is a coloring substance such as many pigments, is accumulated in a concentrated state at the tip of the flocked area of the pattern display area 100.

  As a result, in the pattern display area 100, the color change in the area where the pattern display area 100 is provided is more clearly perceived by the human eye than in the area where the pattern display area 100 is not provided. . Thereby, it is possible to enhance the feeling of use of the chemical volatilizer 1A, and to enhance the effect and effectiveness of the chemicals and the like applied to the chemical volatilizer 1A.

(Suction suction member 6)
Hereinafter, with reference to FIG. 7, the detailed cross-sectional structure of the suction volatilization member 6 which has the above-mentioned pattern display area 100 is demonstrated. The wicking volatilization member 6 is perpendicular to the surface layer 120 by the adhesive layer 130 in the fiber layer 110 that sucks up the prescription liquid 4, the surface layer 120 that covers the surface side of the fiber layer 110, and a part of the surface layer 120. A fiber extending in the direction is attached and has a flocked region 140 constituting the pattern display region 100.

  The fiber layer 110 is required to have a function excellent in the suction and volatilization effect of the prescription liquid 4 utilizing the capillary phenomenon. The fiber can be composed of a fibrous material such as natural fiber such as vegetable fiber or pulp, synthetic fiber such as rayon, polyester, polyethylene terephthalate, polypropylene, polyethylene, or mixed fiber thereof.

  In addition, when the prescription liquid which mix | blended the non-volatile substance (pigment) with the volatile aqueous liquid is used as the prescription liquid 4, natural fibers, such as a vegetable fiber and a pulp, and rayon are suitable, and the prescription liquid 4 is used. Polyester, polyethylene terephthalate, polypropylene, and polyethylene are preferable when a prescription liquid in which a nonvolatile substance (pigment) is blended with a volatile oil-based liquid is used.

  The fiber layer 110 is made of a low-melting fiber (such as polypropylene or polyethylene having a low melting point) such as a natural fiber such as plant fiber or pulp, or a fibrous material such as rayon, synthetic fiber such as polyester, polyethylene terephthalate, polypropylene, or polyethylene, or a mixed fiber thereof. The synthetic fiber) is manufactured by a manufacturing method such as a thermal bond method and an airlaid method in which the synthetic fibers are mixed and thermally welded, or a needle punch method in which the fibers are entangled with each other. In addition, a layer such as a woven fabric or a knitted fabric may be used.

  The thickness of the fiber layer 110 is not particularly limited, but is about 2 mm to about 20 mm from the viewpoint of the size of the container 3, handleability, and functions to be imparted (aroma effect / deodorizing effect / deodorizing effect / insect repellent effect, etc.). Is preferred. In particular, when the entire shape is a belt and needs to be bent so as to be folded, although depending on the basis weight, the thickness is preferably about 10 mm or less, and the volatilization portion 6b can be up to about 20 mm in thickness.

  Moreover, the fiber layer 110 does not necessarily need to be comprised with the layer of fibrous material. For example, a sponge material made of a synthetic resin such as knitted fabric or urethane foam can be used as long as the prescription liquid can be sucked up by utilizing the capillary phenomenon.

  The surface layer 120 has a function of retaining the shape of the fibrous material constituting the internal fiber layer 110 and has an effect of giving the suction volatilization member 6 strength to withstand external force such as tension. In addition, by providing the surface layer 120 on the fiber layer 110, fuzzing on the surface of the fiber layer 110 and dropping of the fibers are suppressed, and the adjustment of the volatilization amount of the formulation liquid 4 from the surface layer 120 and the incorporation into the formulation liquid 4 Fiber elution can also be prevented.

  For the surface layer 120, a nonwoven fabric composed of fibers such as rayon, acrylic, polyester, polypropylene, polyethylene, or a paper-like material such as pulp is used. The thickness is preferably about 0.1 mm to 1 mm, although it depends on the basis weight. As the fiber layer 120, a non-woven fabric manufactured by a spunbond method, a spunlace method, a thermal bond method, or the like is preferable. Is held.

  The flocked region 140 is made of a fiber that is easily charged with static electricity, such as acrylic, polyester, or nylon, and the length of the exposed portion is preferably 5 mm or less. Moreover, the number of implantation is 1000 to 100,000 per 1 cm <2>, More preferably, about 10,000 to 50,000 are preferable.

(Manufacturing method of wicking volatilization member 6)
The suction volatilization member 6 can be manufactured by the following method. Main fibers constituting the fiber layer 110 of the wicking volatilization member 6 are natural fibers such as plant fibers and pulp, artificial fibers, or mixed fibers thereof as described above. First, the fibrous material is crushed. Shorten it. The heat-fusible fiber is mixed as uniformly as possible with the fibrous material. With this mixture, for example, a sheet-like web is formed.

  When the surface layer 120 is formed, fibers such as thin rayon are overlapped on both sides of the fiber layer 110. Next, the web sandwiched by the surface layer 120 is heated to a temperature higher than the melting temperature of the heat-fusible fiber and not damaged by other materials. By this heating, the fiber layer 110 of the wicking volatilization member 6 in which the shape of the fiber layer 110 is maintained can be formed.

  As the heat-fusible fiber, for example, polyethylene fiber, polypropylene fiber, polyvinyl chloride fiber or the like can be used. In addition to the heat-fusible fiber, a liquid binder can be used as the binder.

  The flocked region 140 can be formed by the following method. The adhesive layer 130 is printed on a predetermined region of the surface layer 120, and the printed adhesive layer 130 is charged with static electricity on the short cut fibers, so that fibers extending in a direction perpendicular to the surface layer 120 are attached. The transplanted hair region 140 is provided. As a material for the adhesive layer 130, urethane, acrylic, vinyl acetate, or the like is used. Use of these materials for the adhesive layer 130 does not prevent the prescription liquid 4 from being sucked into the fibers in the flocked region 140.

(Prescription liquid 4)
The prescription liquid 4 used in this Embodiment is demonstrated. In the case of using a formulation liquid 4 in which a volatile aqueous liquid is mixed with a non-volatile substance, the volatile aqueous liquid contains water or a solvent having a relatively high hydrophilicity as a main component (solvent). Can be used. Examples of the solvent having a relatively high hydrophilicity include 3-methoxy-3-methyl-1-butanol, dipropylene glycol, ethanol and the like, but unless the water-repellent effect by the water-repellent layer is hindered, It is not limited to these. When a volatile oil-based component such as a fragrance is to be blended, it can be appropriately solubilized or emulsified by a known method using a surfactant or the like (a water-repellent layer can also be blended with an oil-based component). As long as the water repellent effect is not hindered).

  For example, when the prescription liquid 4 is an aqueous liquid fragrance, water 94%, nonionic surfactant (polyoxyalkylene branched decyl ether) 3%, lavender-like blended fragrance 2%, solvent (3-methoxy-3 -Methyl-1-butanol) as 1%, a volatile aqueous liquid can be prepared.

  Based on the volatile aqueous liquid prepared as described above, an appropriate amount (a trace amount) of a dye or pigment is used as a non-volatile substance. Examples include food yellow No. 4, food blue No. 1, Acid Red 52, Pigment Blue 15: 3, Pigment Violet 23, Pigment Yellow 17, and the like, but are not particularly limited thereto. In addition to these, surfactants, emulsifiers, preservatives, UV absorbers, deodorants, insecticides, insecticides, repellents and the like are appropriately blended as necessary.

  When the formulation liquid 4 is a mixture of a volatile oil-based liquid and a non-volatile substance, a fragrance or an oil-based solvent can be used as a main component as the volatile oil-based liquid. Examples of the oil-based solvent include isoparaffin, polybutene, propylene glycol monopropyl ether, hexyl laurate, isopropyl myristate, and the like, but are not limited thereto as long as absorption into the lipophilic layer is promoted. Also in this case, when a small amount of an aqueous component (an effective component such as a deodorant) is to be blended, it can be appropriately solubilized or emulsified by a known method using a surfactant or the like (aqueous component) Is also acceptable as long as absorption promotion by the lipophilic layer is not hindered).

  For example, when the prescription liquid 4 is an oil-based liquid fragrance, it can be prepared as an oil-based solvent (isoparaffin) 70% and a lavender-like blended fragrance 30%.

  Based on the volatile oil-based liquid prepared as described above, an appropriate amount (a trace amount) of pigment or dye is added as a non-volatile substance. For example, Solvent Green 29, Solvent Red 146, Disperse Yellow 54, etc. are exemplified, but not limited thereto. In addition to these, surfactants, emulsifiers, preservatives, UV absorbers, deodorants, insecticides, insecticides, repellents and the like are appropriately blended as necessary.

  As described above, according to the chemical volatilizer 1A in the present embodiment, the pattern display region 100 formed by the flocked region 140 is provided in the volatilization portion 6b. Thereby, the prescription liquid 4 is volatilized from the front-end | tip part of the flocked area | region 140 of the pattern display area 100 through the fiber layer 110 and the surface layer 120 by a capillary phenomenon.

  As a result, although it is the same color tone as a whole at the start of use, with the passage of time, in the volatilization part 6b, compared with the area | region where the flocking area | region 140 is not provided, the front-end | tip part of the flocking area | region 140 of the pattern display area 100 More of the dye of the prescription liquid 4 is accumulated. As a result, the color of the pigment at the tip of the flocked area of the pattern display area 100 gradually increases. As a result, as shown in FIG. 6B, a floral pattern clearly appears on the volatilization portion 6b, and in the pattern display area 100, the pattern display area 100 is more than in the area where the pattern display area 100 is not provided. The change in color in the region where is provided is clearly perceived by the human eye. Thereby, it is possible to enhance the feeling of use of the chemical volatilizer 1A, and to enhance the effect and effectiveness of the chemicals and the like applied to the chemical volatilizer 1A.

  In addition, in FIG. 7, although the surface layer 120 was formed on the fiber layer 110 and the flocked area | region 140 was formed on this surface layer 120 as a structure of the wicking volatilization member 6, this structure was demonstrated. Not limited to. For example, as shown in FIG. 8, it is possible to adopt a configuration in which the flocked region 140 is provided on the fiber layer 110 with the adhesive layer 130 interposed without providing the surface layer 120.

  As another configuration, as shown in FIG. 9, when using fibers that extend in parallel along the surface of the fiber layer 110 (for example, curtain fabric), the short fibers constituting the flocked region 140 are directly used. It is also possible to adopt a structure for flocking. Further, the structure in which short fibers are directly planted can be formed by cutting pile fibers.

  In addition, although the case where the flocking area | region 140 was used as an example of the pattern display area | region 100 was demonstrated, it is not limited to this structure. For example, in the case where the surface roughness of the area where the pattern display area 100 is provided in the volatilization part 6b is larger than the surface roughness of the area where the pattern display area 100 is not provided, the prescription is given to the surface roughness larger due to capillary action. The liquid 4 is sucked up more and volatilizes.

  For example, when the flocked region 140 is used in the pattern display region 100 as described above, the surface roughness in the flocked region 140 is expressed by a friction coefficient, and the value is 0.4 μ to 1.0 μ (mu). (Measured with Kato Tech Co., Ltd. KES-SE friction tester: Measurement conditions Sensitivity = H, SPEED = 1.0 mm / s, static load = 50 g), preferably 0.4 μ to 0.8 μ. The surface roughness of the volatilized portion 6b where the flocked region 140 is not provided has a friction coefficient value of 0.3 μm or less, and preferably 0.2 μm or less.

  Therefore, if the surface roughness of the area where the pattern display area 100 is provided in the volatilization part 6b is 0.4 μm or more and the surface roughness of the area where the pattern display area 100 is not provided is 0.3 μm or less, the surface roughness In the large picture display area 100, the prescription liquid 4 is sucked up more by capillary action, and volatilization is promoted. As a result, the color of the pigment in the pattern display area 100 becomes darker than that in the area where the pattern display area 10 is not provided, and the floral pattern can clearly appear on the volatilization portion 6b.

(Embodiment 2)
In the chemical volatilizer 1A in the first embodiment, the case where the suction part 6a and the volatilization part 6b are continuously integrated and the mechanism in which the volatilization part 6b is exposed to the outside air by pulling up the holding frame 8 will be described. did.

  The chemical volatilizer 1B in the present embodiment is configured such that the suction part 6a and the volatilization part 6b are separated from each other, and are in contact with each other during use, and the prescription liquid 4 moves from the suction part 6a to the volatilization part 6b. Is. About the structure of the prescription liquid 4 and the volatilization part 6b, the thing similar to the structure shown in FIG. 7 of the said Embodiment 1 can be used. Therefore, in the following description, the structure of the chemical volatilizer 1B will be described.

(Overall configuration of drug volatilizer 1B)
First, with reference to FIG. 10, the whole structure of the chemical volatilizer 1B in this Embodiment before use is demonstrated. The suction part 6 a is held by a support member 15 provided in the opening 2 of the container 3. A part of the tip of the suction part 6 a is held by the support member 15 in a state of protruding from the opening 2 of the container 3. A cap 16 is screwed onto the outer periphery of the opening 2 so as to cover the upper part of the suction part 6 a protruding from the opening 2 of the container 3.

  A volatilization part support member 17 that supports the volatilization part 6 b is fixed to the upper part of the container 3 in a removable state with respect to the container 3. The volatilization part 6b is supported by the volatilization part support member 17 in a state where the surface part is exposed to the outside.

  With reference to FIG. 11, the state at the time of use of the chemical volatilizer 1B is demonstrated. At the time of use, the volatilization part support member 17 is once removed from the container 3. Next, the cap 16 is removed from the opening 2 of the container 3. Next, the volatilization part support member 17 is fixed to the container 3 again.

  Thereby, the front-end | tip of the suction part 6a which protrudes from the opening part 2 of the container 3 will be in the state which contacts the volatilization part 6b currently supported by the volatilization part support member 17, and the prescription liquid 4 goes to the volatilization part 6b from the suction part 6a. It becomes possible to move to. The protrusion 17 a provided on the inner periphery of the volatilization part support member 17 is fitted into the groove part 3 a of the container 3, whereby the volatilization part support member 17 can be fixed to the container 3.

  Positioning of the volatilization part support member 17 with respect to the container 3 is performed by fitting the convex parts 17a provided on the volatilization part support member 17 into the plurality of groove parts 3a provided in the container 3 and the predetermined groove parts 3a.

  Thus, when it is comprised so that the suction part 6a and the volatilization part 6b may contact at the time of use, the shape of the volatilization part 6b is various, such as block shape, disk shape, and other more complicated shapes. Various shapes can be employed.

  As described above, according to the drug volatilizer 1B in the second embodiment, similarly to the drug volatilizer 1A in the first embodiment, the volatilization unit 6b capable of locally expressing the floral pattern is provided. It becomes possible to provide a chemical volatilizer.

  Specifically, in the pattern display area 100, at the beginning when the suction part 6a and the volatilization part 6b are in contact with each other, as shown in FIG. 12A, the volatilization part 6b and the flocked area 140 that is the pattern display area 100, In the meantime, the color contrast is not greatly generated, but the dye of the prescription liquid 4 is accumulated on the surface of the flocked region 140 which is the picture display region 100 as time passes. Thereby, as shown to FIG. 12 (B), a floral pattern can be clearly surfaced in the volatilization part 6b.

  In each of the above embodiments, a case where a floral pattern is adopted as an example of the pattern display area 100 is described. However, the pattern is not limited to a floral pattern, and animals, buildings, cartoon characters, and the like. By adopting a picture, a pattern, a pattern, a character, or a region displayed by combining these, it is possible to improve the design of the volatilization part.

  Although the embodiments of the present invention have been described above, the embodiments disclosed this time should be considered as illustrative in all points and not restrictive. The scope of the present invention is defined by the terms of the claims, and is intended to include any modifications within the scope and meaning equivalent to the terms of the claims.

  1A, 1B volatilizer, 2 openings, 3 container, 3a groove, 4 formulation liquid, 6 suction volatilization member, 6a suction top, 6b volatilization part, 7 cap, 7a boss, 7b tip head, 7c stepped part, 8 Holding frame, 8a outer frame, 8b engaging part, 9 connecting part, 9a fitting hole, 9b reinforcing plate, 14 neck part, 15 supporting member, 16 cap, 17 volatilization part supporting member, 17a convex part, 100 pattern display area, 110 fiber layer, 120 surface layer, 130 adhesive layer, 140 flocked area.

Claims (9)

A container having an opening;
A prescription solution containing a non-volatile substance in a volatile liquid contained in the container;
An evacuation and volatilization member that is disposed in the opening and sucks up the prescription liquid and volatilizes the volatile liquid in the prescription liquid;
With
A pattern display area is provided on the surface of the wicking member,
The pattern display area has a surface roughness of the pattern display area that is not provided with the pattern display area so that the prescription liquid is sucked more toward the tip by capillary action. A chemical volatilizer provided larger than the surface roughness of the member. The wicking member has a fiber layer that sucks up the prescription liquid, and a surface layer that covers the surface of the fiber layer,
The drug volatilizer according to claim 1, wherein the pattern display region is formed on the surface layer.   The chemical volatilization device according to claim 1 or 2, wherein the pattern display region is a flocked region extending in a direction substantially perpendicular to the surface of the suction volatilization member.   The chemical volatilizer according to any one of claims 1 to 3, wherein a friction coefficient of the pattern display area is set larger than a friction coefficient of the suction volatilization member in an area where the pattern display area is not provided. The coefficient of friction of the pattern display area is 0.4 μm or more,
The chemical volatilization device according to claim 4, wherein a coefficient of friction of the suction volatilization member in a region where the pattern display region is not provided is 0.3 µm or less.   The chemical volatilizer according to any one of claims 1 to 5, wherein the non-volatile substance is a pigment.   The said suction volatilization member has a suction part and a volatilization part, The chemical | medical agent volatilization device in any one of Claim 1 to 6 with which the said pattern display area | region is provided in the said volatilization part.   The chemical vaporizer according to claim 7, wherein the suction and volatilization member is formed by integrating the suction part and the volatilization part continuously.   The chemical vaporizer according to claim 7, wherein the wicking member is provided such that the wicking portion and the volatile portion are separated and the wicking portion and the volatile portion are in contact with each other during use. .

Images